TPH2
Tryptophan 5-hydroxylase 2
Also known as: FLJ37295, NTPH, TPH2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IWU9
- Gene
- TPH2
- Ensembl
- ENSG00000139287
- Chromosome
- 12
- Canonical length
- 490 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the pterin-dependent aromatic acid hydroxylase family. The encoded protein catalyzes the first and rate limiting step in the biosynthesis of serotonin, an important hormone and neurotransmitter. Mutations in this gene may be associated with psychiatric diseases such as bipolar affective disorder and major depression. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
490 residues, UniProt reviewed canonical sequence.
>Q8IWU9|TPH2
1 MQPAMMMFSS KYWARRGFSL DSAVPEEHQL LGSSTLNKPN SGKNDDKGNK GSSKREAATE
61 SGKTAVVFSL KNEVGGLVKA LRLFQEKRVN MVHIESRKSR RRSSEVEIFV DCECGKTEFN
121 ELIQLLKFQT TIVTLNPPEN IWTEEEELED VPWFPRKISE LDKCSHRVLM YGSELDADHP
181 GFKDNVYRQR RKYFVDVAMG YKYGQPIPRV EYTEEETKTW GVVFRELSKL YPTHACREYL
241 KNFPLLTKYC GYREDNVPQL EDVSMFLKER SGFTVRPVAG YLSPRDFLAG LAYRVFHCTQ
301 YIRHGSDPLY TPEPDTCHEL LGHVPLLADP KFAQFSQEIG LASLGASDED VQKLATCYFF
361 TIEFGLCKQE GQLRAYGAGL LSSIGELKHA LSDKACVKAF DPKTTCLQEC LITTFQEAYF
421 VSESFEEAKE KMRDFAKSIT RPFSVYFNPY TQSIEILKDT RSIENVVQDL RSDLNTVCDA
481 LNKMNQYLGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 0.5 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 0.5 nTPM
- pituitary gland: 0.4 nTPM
- hypothalamus: 0.3 nTPM
- hippocampal formation: 0.2 nTPM
- pancreas: 0.2 nTPM
- midbrain: 0.1 nTPM
Single-cell type
- epicardial cells: 141 nCPM
- somatotrophs: 26 nCPM
- other brain neurons: 24 nCPM
- lactotrophs: 19 nCPM
- late spermatids: 15 nCPM
- early spermatids: 15 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 632 nTPM
- pons: 271 nTPM
- medulla oblongata: 96 nTPM
- hippocampal formation: 2.6 nTPM
- hypothalamus: 1.2 nTPM
- thalamus: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TPH2.
Disease | AllUniProt
Conditions TPH2 is implicated in, by any mechanism.
- Major depressive disorder (MDD) MIM:608516
- Attention deficit-hyperactivity disorder 7 (ADHD7) MIM:613003
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aromatic amino acid hydroxylase
- ACT domain
- Tryptophan 5-monooxygenase
- Aromatic amino acid hydroxylase, iron/copper binding site
- Tyrosine 3-monooxygenase-like
- Aromatic amino acid hydroxylase, C-terminal
- Aromatic amino acid monoxygenase, C-terminal domain superfamily
- Aromatic amino acid hydroxylase superfamily
- Tryptophan 5-hydroxylase, catalytic domain
- ACT-like domain
- Biopterin-dependent aromatic amino acid hydroxylase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TPH2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPH2 as an antibody target. Whether an autoantibody or antibody against TPH2 could matter depends on whether native TPH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...